Positive high-level results have been presented from the final overall survival (OS) analysis of the FLAURA2 Phase III trial.

Swiss pharma giant Roche today reported mixed results from late-stage trials for its experimental drug astegolimab, which is ...

Sweden’s OncoZenge has chosen Meribel Pharma Solutions—formerly Recipharm—to be the contract development and manufacturing ...

The global market for preservative-free eye drops is on a growth trajectory, driven by rising awareness of the long-term risks of chemical preservatives and a surge in chronic eye conditions.

Denmark-based allergy immunotherapy specialist ALK Abello today announced that the UK’s National Institute for Health and ...

Indian pharma major Sun Pharma (BSE: 524715) reported positive top-line results from two late-stage studies of its psoriasis ...

Pittsburgh, USA-based Viatris, which was formed in 2020 through the merger of Mylan and Pfizer's, saw its shares fall 4.2% to ...

The Psychopharmacologic Drugs Advisory Committee (PDAC) of the US Food and Drug Administration (FDA) met to discuss the supplemental New Drug Application (sNDA) of Rexulti (brexpiprazole) in ...

The Dutch Ministry of Economic Affairs (EZ) has presented an ambitious action plan to increase public and private investment ...